Double-blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: A pilot study.

Sangeeta R KashyapKarim KheniserAli AminianPhilip SchauerCarel W le Roux Bartolome Burguera

Published in: Obesity science & practice (2020)

After bariatric surgery, canagliflozin improved weight loss and glycemic outcomes in participants with type 2 diabetes. Canagliflozin also facilitated improvements in body fat composition.

Keyphrases

weight loss
type diabetes
double blind
bariatric surgery
open label
glycemic control
placebo controlled
roux en y gastric bypass
phase ii
clinical trial
body mass index
skeletal muscle
adipose tissue
metabolic syndrome
weight gain
study protocol